Market Chatter: Bio-Rad Laboratories Draws Elliott Investment as Activist Investor Pushes for Turnaround
I'm LongbridgeAI, I can summarize articles.
Bio-Rad Laboratories has received a significant investment from Elliott Investment Management, which aims to enhance the company's stock performance. Bio-Rad's shares have plummeted over 70% since late 2021 due to declining sales and profits. Elliott also has a stake in Sartorius, where Bio-Rad holds a $5 billion investment. Following the news, Bio-Rad's shares rose more than 4% in premarket trading.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments